IRIDEX CORP

IRIX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010
Revenue $31.0M
Cost of Revenue $15.6M
Gross Profit $15.4M
Gross Margin 49.8%
Operating Expenses
Research & Development $3.3M
SG&A Expense $4.3M
Operating Income $1.2M
Operating Margin 4.0%
Interest Expense
Pretax Income $1.8M
Income Tax Expense $262.0K
Net Income $2.6M
Net Margin 8.3%
EPS (Basic) $0.17
EPS (Diluted) $0.16
Shares Outstanding (Basic) 8.8M
Shares Outstanding (Diluted) 9.9M
Dividends Per Share
← Newer Page 3 of 3 Older →